기능성 삼첨판막 역류-임상적 의의와 적절한 수술 시기

키워드

참고문헌 (54)

1. Nihoyannopoulos P, "Tricuspid valvectomy following tricuspid valve endocarditis on an intravenous drug addict", Heart, 86, pp.144~ (2001)
2. Kim HK, "Impact of the maze operation combined with left-sided valve surgery on the change in tricuspid regurgitation over time", Circulation, 112(9Suppl), pp.14~19 (2005)
3. Kwak JJ, "Development of tricuspid regurgitation late after left-sided valve surgery : a single-center experience with long-term echocardiographic examinations", Am Heart J, 155, pp.732~737 (2008)
4. Kim YJ, "Determinants of surgical outcome in patients with isolated tricuspid regurgitation", Circulation, 120, pp.1672~1978 (2009)
5. Kim JB, "Surgical outcomes of severe tricuspid regurgitation : predictors of adverse clinical outcomes", Heart, 99, pp.181~187 (2013)
6. Topilsky Y, "Preoperative factors associated with adverse outcome after tricuspid valve replacement", Circulation, 123, pp.1929~1939 (2011)
7. Kim HK, "Assessment of haemodynamic effects of surgical correction for severe functional tricuspid regurgitation : cardiac magnetic resonance imaging study", Eur Heart J, 31, pp.1520~1528 (2010)
8. Groves PH, "Reduced exercise capacity in patients with tricuspid regurgitation after successful mitral valve replacement for rheumatic mitral valve disease", Br Heart J, 66, pp.295~301 (1991)
9. Nath J, "Impact of tricuspid regurgitation on long-term survival", J Am Coll Cardiol, 43, pp.405~409 (2004)
10. Czer LS, "Tricuspid valve repair. Operative and follow-up evaluation by Doppler color flow mapping", J Thorac Cardiovasc Surg, 98, pp.101~110 (1989)
11. Goldman ME, "The necessity for tricuspid valve repair can be determined intraoperatively by two-dimensional echocardiography", J Thorac Cardiovasc Surg, 94, pp.542~550 (1987)
12. Hannoush H, "Regression of significant tricuspid regurgitation after mitral balloon valvotomy for severe mitral stenosis", Am Heart J, 148, pp.865~870 (2004)
13. McGrath LB, "Tricuspid valve operations in 530 patients. Twenty-five-year assessment of early and late phase events", J Thorac Cardiovasc Surg, 99, pp.124~133 (1990)
14. Porter A, "Tricuspid regurgitation late after mitral valve replacement : clinical and echocardiographic evaluation", J Heart Valve Dis, 8, pp.57~62 (1999)
15. Je HG, "Impact of the Maze operation on the progression of mild functional tricuspid regurgitation", J Thorac Cardiovasc Surg, 136, pp.1187~1192 (2008)
16. Matsuyama K, "Predictors of residual tricuspid regurgitation after mitral valve surgery", Ann Thorac Surg, 75, pp.1826~1828 (2003)
17. Izumi C, "Progression of isolated tricuspid regurgitation late after mitral valve surgery for rheumatic mitral valve disease", J Heart Valve Dis, 11, pp.353~356 (2002)
18. Stulak JM, "Restoration of sinus rhythm by the Maze procedure halts progression of tricuspid regurgitation after mitral surgery", Ann Thorac Surg, 86, pp.40~44 (2008)
19. Ubago JL, "Analysis of the amount of tricuspid valve anular dilatation required to produce functional tricuspid regurgitation", Am J Cardiol, 52, pp.155~158 (1983)
20. Mikami T, "Mechanisms for development of functional tricuspid regurgitation determined by pulsed Doppler and two-dimensional echocardiography", Am J Cardiol, 53, pp.160~163 (1984)
21. Come PC, "Tricuspid anular dilatation and failure of tricuspid leaflet coaptation in tricuspid regurgitation", Am J Cardiol, 55, pp.599~601 (1985)
22. Fukuda S, "Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty", Circulation, 111, pp.975~979 (2005)
23. Fukuda S, "Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty", Circulation, 114(1 Suppl), pp.582~587 (2006)
24. Kim HK, "Determinants of the severity of functional tricuspid regurgitation", Am J Cardiol, 98, pp.236~242 (2006)
25. Min SY, "Geometric changes after tricuspid annuloplasty and predictors of residual tricuspid regurgitation : a real-time three-dimensional echocardiography study", Eur Heart J, 31, pp.2871~2880 (2010)
26. Bonow RO, "Focused update incorporated into the ACC", AHA 2006guidelines for the management of patients with valvular heart disease : a report of the American College of Cardiology, Circulation, pp.2008, 118[DOI]
27. Yang WI, "Vena contracta width as a predictor of adverse outcomes in patients with severe isolated tricuspid regurgitation", J Am Soc Echocardiogr, 24, pp.1013~1019 (2011)
28. Park K, "Incremental prognostic value of early postoperative right ventricular systolic function in patients undergoing surgery for isolated severe tricuspid regurgitation", Heart, 97, pp.1319~1325 (2011)
29. Filsoufi F, "Long-term outcomes of tricuspid valve replacement in the current era", Ann Thorac Surg, 80, pp.845~850 (2005)
30. Vahanian A, "Guidelines on the management of valvular heart disease : The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology", Eur Heart J, 28, pp.230~268 (2007)
31. Nishimura RA, "2014AHA", ACC guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63[DOI]
32. Joint Task Force on the Management of Valvular Heart Dise ase of the European Society of Cardiology, "Guidelines on the management of valvular heart disease(version 2012)", Eur Heart J, 33, pp.2451~2496 (2012)
33. Kwon DA, "Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mitral valve surgery and role of tricuspid annular systolic velocity", Am J Cardiol, 98, pp.659~661 (2006)
34. Haeck ML, "Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension", Circ Cardiovasc Imaging, 5, pp.628~636 (2012)
35. Kaul S, "Assessment of right ventricular function using two-dimensional echocardiography", Am Heart J, 107, pp.526~531 (1984)
36. Forfia PR, "Tricuspid annular displacement predicts survival in pulmonary hypertension", Am J Respir Crit Care Med, 174, pp.1034~1041 (2006)
37. Dini FL, "Prognostic significance of tricuspid annular motion and plasma NT-proBNP in patients with heart failure and moderate-to-severe functional mitral regurgitation", Eur J Heart Fail, 10, pp.573~580 (2008)
38. Damy T, "Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion(TAPSE)among out-patients referred for the evaluation of heart failure", J Card Fail, 18, pp.216~225 (2012)
39. Hsiao SH, "Severe tricuspid regurgitation shows significant impact in the relationship among peak systolic tricuspid annular velocity, tricuspid annular plane systolic excursion, and right ventricular ejection fraction", J Am Soc Echocardiogr, 19, pp.902~910 (2006)
40. Anand IS, "Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery", Circulation, 86, pp.12~21 (1992)
41. Anand IS, "Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure : results from Val-HeFT", Circulation, 112, pp.1121~1127 (2005)
42. Go AS, "Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure : the Anemia in Chronic Heart Failure : Outcomes and Resource Utilization(ANCHOR)Study", Circulation, 113, pp.2713~2723 (2006)
43. 최동주, "Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure: A Report From the Korean Heart Failure Registry", Korean Circulation Journal, 41(7), pp.363~371 (2011), 대한심장학회
44. Maeder MT, "Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure", J Am Coll Cardiol, 58, pp.474~480 (2011)
45. Okonko DO, "Disordered iron homeostasis in chronic heart failure : prevalence, predictors, and relation to anemia, exercise capacity, and survival", J Am Coll Cardiol, 58, pp.1241~1251 (2011)
46. Comin-Colet J, "The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency : a subanalysis of the FAIR-HF study", Eur Heart J, 34, pp.30~38 (2013)
47. Avni T, "Iron supplementation for the treatment of chronic heart failure and iron deficiency : systematic review and meta-analysis", Eur J Heart Fail, 14, pp.423~429 (2012)
48. Mukoyama M, "Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide", J Clin Invest, 87, pp.1402~1412 (1991)
49. Rademaker MT, "Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure : role of natriuretic peptides and angiotensin II", J Cardiovasc Pharmacol, 31, pp.116~125 (1998)
50. Galie N, "Ambrisentan for the treatment of pulmonary arterial hypertension : results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy(ARIES)study 1 and 2", Circulation, 117, pp.3010~3019 (2008)
51. Detaint D, "B-type natriuretic peptide in organic mitral regurgitation : determinants and impact on outcome", Circulation, 111, pp.2391~2397 (2005)
52. Pizarro R, "Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation", J Am Coll Cardiol, 54, pp.1099~1106 (2009)
53. Hwang IC, "Prognostic value of B-type natriuretic peptide in patients with chronic mitral regurgitation undergoing surgery : mid-term follow-up results", Eur J Cardiothorac Surg, 43, pp.1~6 (2013)
54. Gammie JS, "Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation", Circulation, 115, pp.881~887 (2007)

관련 논문AI추천